fbpx

ADVERTISEMENT

ADVERTISEMENT

Brain Metastasis

Updated : June 21, 2022





Background

Brain metastases are the most prevalent sort of brain tumor and a major cancer consequence. Brain metastases affect ten percent to twenty-six percent of cancer patients who die.

While conventional medicines can only cure a small percentage of malignancies that spread to the brain, palliation and long-term survival are achievable with the least side effects for patients.

As survival rates rise, quality of life and neuro-cognition are becoming more widely recognized as key outcomes for patients.

Epidemiology

The most prevalent type of intracranial cancer is brain metastasis. Each year, between 98,000 and 170,000 instances are diagnosed in the United States. Brain metastases are becoming more common as a result of a number of reasons.

With novel systemic medicines (such as immunotherapy) that have lately become more widely used, sufferers with systemic metastatic cancer have a longer survival time.

Additionally, the increased use of precise MRI (magnetic resonance imaging) procedures has aided in the diagnosis of tiny symptomless brain metastases.

Anatomy

Pathophysiology

Through a breach of the blood-brain barriers, metastatic cancer spreads through into the bloodstream and into the central nervous system. Clonal cells then multiply, generating invasion, displacement, inflammation, and edema in the affected area.

In locations with strong blood flow, distribution across the central nervous system is more typical; nevertheless, various histological subgroups have varying distributions of the area inside the brain.

Etiology

Cancers of the lung, melanoma, and breast are the most prone to spread to the brain. Because small-cell tumor seems to have a high proclivity for spreading to the brain, preventive care (cranial irradiation) is the gold standard.

Brain metastases are uncommon in other tumors, such as head and neck carcinoma and prostate. Other than tumor kind and subgroup, it might be difficult to determine which patients would progress cerebral metastases.

Genetics

Prognostic Factors

The prognosis of brain metastasis is determined by a number of variables, including:

  • Patients age
  • Size and number of metastases
  • The primary tumor’s location
  • The additional metastasis sites
  • The existence of a mass effect
  • The tumor’s radiosensitivity and chemosensitivity

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

Media Gallary

References

https://www.ncbi.nlm.nih.gov/books/NBK470246/

ADVERTISEMENT 

Brain Metastasis

Updated : June 21, 2022




Brain metastases are the most prevalent sort of brain tumor and a major cancer consequence. Brain metastases affect ten percent to twenty-six percent of cancer patients who die.

While conventional medicines can only cure a small percentage of malignancies that spread to the brain, palliation and long-term survival are achievable with the least side effects for patients.

As survival rates rise, quality of life and neuro-cognition are becoming more widely recognized as key outcomes for patients.

The most prevalent type of intracranial cancer is brain metastasis. Each year, between 98,000 and 170,000 instances are diagnosed in the United States. Brain metastases are becoming more common as a result of a number of reasons.

With novel systemic medicines (such as immunotherapy) that have lately become more widely used, sufferers with systemic metastatic cancer have a longer survival time.

Additionally, the increased use of precise MRI (magnetic resonance imaging) procedures has aided in the diagnosis of tiny symptomless brain metastases.

Through a breach of the blood-brain barriers, metastatic cancer spreads through into the bloodstream and into the central nervous system. Clonal cells then multiply, generating invasion, displacement, inflammation, and edema in the affected area.

In locations with strong blood flow, distribution across the central nervous system is more typical; nevertheless, various histological subgroups have varying distributions of the area inside the brain.

Cancers of the lung, melanoma, and breast are the most prone to spread to the brain. Because small-cell tumor seems to have a high proclivity for spreading to the brain, preventive care (cranial irradiation) is the gold standard.

Brain metastases are uncommon in other tumors, such as head and neck carcinoma and prostate. Other than tumor kind and subgroup, it might be difficult to determine which patients would progress cerebral metastases.

The prognosis of brain metastasis is determined by a number of variables, including:

  • Patients age
  • Size and number of metastases
  • The primary tumor’s location
  • The additional metastasis sites
  • The existence of a mass effect
  • The tumor’s radiosensitivity and chemosensitivity

https://www.ncbi.nlm.nih.gov/books/NBK470246/

Free CME credits

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

Digital Certificate PDF

On course completion, you will receive a full-sized presentation quality digital certificate.

medtigo Simulation

A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

medtigo Points

medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
 
  • Registration with medtigo = 10 points
  • 1 visit to medtigo’s website = 1 point
  • Interacting with medtigo posts (through comments/clinical cases etc.) = 5 points
  • Attempting a game = 1 point
  • Community Forum post/reply = 5 points

    *Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.

All Your Certificates in One Place

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.

Our Certificate Courses